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Abstract
Genetic analyses in Drosophila epithelia have suggested that the phenomenon of ‘‘cell competition’’ could participate in
organ homeostasis. It has been speculated that competition between different cell populations within a growing organ
might play a role as either tumor promoter or tumor suppressor, depending on the cellular context. The evolutionarily
conserved Hippo (Hpo) signaling pathway regulates organ size and prevents hyperplastic disease from flies to humans by
restricting the activity of the transcriptional cofactor Yorkie (yki). Recent data indicate also that mutations in several Hpo
pathway members provide cells with a competitive advantage by unknown mechanisms. Here we provide insight into the
mechanism by which the Hpo pathway is linked to cell competition, by identifying dMyc as a target gene of the Hpo
pathway, transcriptionally upregulated by the activity of Yki with different binding partners. We show that the cellautonomous upregulation of dMyc is required for the supercompetitive behavior of Yki-expressing cells and Hpo pathway
mutant cells, whereas the relative levels of dMyc between Hpo pathway mutant cells and wild-type neighboring cells are
critical for determining whether cell competition promotes a tumor-suppressing or tumor-inducing behavior. All together,
these data provide a paradigmatic example of cooperation between tumor suppressor genes and oncogenes in
tumorigenesis and suggest a dual role for cell competition during tumor progression depending on the output of the
genetic interactions occurring between confronted cells.
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Università di Bologna, in the first part of the work and currently is supported by the ‘‘Fondazione Cassa di Risparmio in Bologna’’. Luis Alberto Baena-López is
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number of cells in the organs is unaffected [3]. The biological
function of cell competition remains unclear but it is thought to
contribute to tissue homeostasis by coordinating the rate of cell
proliferation and cell death [4,5]. One of the best examples
illustrating cell competition was obtained from the analysis of
Drosophila myc [4,5], opening to the speculation that this
phenomenon might play a role in tumorigenesis [2,6], however
the basis of cell competition in tumorous situations has just begun
to be investigated [7]. dmyc is an evolutionarily conserved protooncogene associated with different cellular processes, including cell
cycle progression, cell growth and apoptosis [8–11]. The function
of dMyc protein is both necessary and sufficient to control rRNA
synthesis and ribosome biogenesis [12]. In Drosophila, cells carrying
hypomorphic alleles of dmyc are viable in a homotypic context, but
they are outcompeted and excluded from the epithelium when

Introduction
Growth regulation requires the fine tuning between the rate of
cell death and cell proliferation in developing organs. Studies in
Drosophila have revealed that somatic cells within a growing
epithelium compete with one another for contribution to the adult
organ and this phenomenon, known as ‘‘cell competition’’ [1], is
possibly conserved among organisms, for a review [2]. Cell
competition was discovered several decades ago comparing the
clonal growth parameters of Drosophila wild type cells (+/+) and
slow-dividing Minute/+ cells [1]. From those analyses and recent
data [3], it has been concluded that the contact between wild type
and slow-growing cells, in genetic mosaics, favors the positive
selection and clonal expansion of faster cells (winners) at the
expense of slow-dividing ones (losers), although eventually the final
PLoS Genetics | www.plosgenetics.org
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them from being eliminated in a competitive background. Finally,
we show that the relative levels of dMyc protein between
neighboring cells are critical in order to define the role of cell
competition during tumor progression.

Author Summary
One of the major challenges of developmental biology and
cancer research is to get a better understanding of how
different signals regulate proper organ growth and
prevent tumor formation. Even though there is a strong
correlation between tumor progression and Myc family
misexpression or Hippo signaling pathway malfunction,
the relationship between these organ growth regulators
remains unclear. Here, we demonstrate that the Hippo
signaling pathway controls the transcription of Drosophila
dmyc. Furthermore, we show that the misregulated
expression of dMyc in Hippo mutant cells elicits their
proliferative expansion at the expense of normal surrounding cells. These findings reveal a molecular mechanism of cooperation between oncogenes and tumor
suppressor genes that favors both tumor progression
and wild-type tissue elimination. Additionally, our findings
indicate a dual role for cell competition during the tumour
progression depending on the cellular context.

Results
Hpo pathway mutant cells display supercompetitive
properties
In order to analyze the competitive properties of Hpo pathway
mutant cells, we used mosaic analysis to compare the size of yki
overexpressing clones (hereafter referred to as ykiover) with their
wild type twins. While clones and twins showed a comparable size
in the wild type control (Figure 1A, 1F, and 1G, and Figure S1A,
S1C, S1D), ykiover clones were notably larger than their wild type
twins in wing discs dissected either 60h (Figure 1D, 1H, and 1I) or
48h (Figure S1B, S1E, S1F) after heat-shock induction. Furthermore, ykiover wild type twins were almost disappeared from the
epithelium at 120h after egg laying (AEL) (Figure 1B and 1C).
These differences in size were also prominent when discs were
dissected at 96h AEL (Figure 1D and 1E). Interestingly, the clonal
expansion of ykiover cells was also correlated with non-autonomous
apoptosis, as revealed by active Caspase 3 immunoreactivity of a
subset of surrounding wild type cells (Figure 1B–1E). The size
advantage of ykiover clones and the induction of apoptosis in wild
type cells is consistent with the broadly assumed definition of cell
competition, which implies that the clonal expansion of the winner
cells occurs at the expense of the juxtaposed losers, that are
eliminated by apoptotic death [2,42,43]. The pattern of cell death
in wild type and ykiover cells (Figure 1B–1E) was not confined to the
interface between the two cell types; as can be seen in Figure 1E,
cell death extends several cell diameters away and wild type cells
tend to die massively when enclosed between nearby mutant
clones (Figure 1E, yellow arrowhead). A similar pattern of nonautonomous cell death was observed in wild type cells nearby
mutant clones for other members of the Hpo pathway, such as ft
and ex (Figure S2A, S2B, S2C). Strikingly, ykiover clones and wts
mutant clones grown for a longer period presented autonomous
cell death (Figure 1C, see active Caspase 3 staining, and Figure
S2D), despite the upregulation of anti-apoptotic molecules such as
dIAP1 [16]; this might be possibly due to either developmental
constraints compensating for excessive proliferation of the entire
organ or toxicity caused by high and constant levels of Yki.
Altogether, these results confirm the previously suggested
supercompetitive properties of the Hpo pathway mutant clones
[19] by revealing their ability to overgrow and eliminate
surrounding wild type cells.

surrounded by wild type cells [5]. By contrast, dmyc overexpressing
cells become ‘‘supercompetitors’’ able to kill wild type surrounding
cells [4,5]. Remarkably, dMyc upregulation is related with many
types of human cancers [13] and it favors the clonal expansion of
cells carrying additional oncogenic mutations [14,15].
During the last years, the Hippo (Hpo) tumor suppressor
pathway has emerged as a safeguard system restricting organ
growth and preventing hyperplastic disease in metazoans [16,17].
Mutations in several members of this pathway have been
associated with tumor formation both in Drosophila and in humans
[18]. It has also been reported that mutations in many members of
the Hpo pathway can rescue the viability of heterozygous M/+
cells in genetic mosaics [19], suggesting that these mutant cells
behave as ‘‘supercompetitors’’. Therefore the detailed analysis of
Hpo pathway members appears to be an attractive model in which
to evaluate the relationship between cell competition and tumor
growth, as well as the molecular mechanisms required for this
crosstalk. Hpo, Salvador (Sav) and Warts (Wts) constitute the core
of the Hpo pathway that regulates by phosphorylation the
downstream transcriptional co-activator Yorkie (Yki) [18,20].
The hyperphosphorylated form of Yki is retained in the cytoplasm
[21,22], thereby preventing the expression of several target genes
involved in cell proliferation control (Cyclin E, E2F1, bantam
miRNA) [16,23–25], cell death (dIAP1) [16] and cell signaling
regulation (dally and dally-like) [26]. It has been demonstrated that
Yki regulates its target genes by binding to Scalloped (Sd), a
TEAD/TEF family transcription factor [27–30]. In addition,
recent data indicate that Yki is also able to bind to the
homeoprotein Homothorax (Hth) forming a complex which
regulates the transcription of bantam in the eye disc [31]. The
atypical cadherins Fat (Ft) [26,32–37] and Dachsous (Ds)
[20,26,33,38], as well as the FERM-domain proteins Expanded
(Ex) and Merlin (Mer) [39], have also been implicated in the
pathway as upstream components. Although their biochemical
functions are still uncertain, it is assumed that they converge on
Wts to regulate Yki activity [40,41].
Here we provide a detailed analysis of the autonomous and nonautonomous effects on growth of yki-expressing cells and mutations
of members of the Hpo pathway. In addition we show that dmyc is
a transcriptional target of Yki, able to confer competitive
properties to the Hpo pathway mutant cells in the Drosophila
wing. Furthermore, dmyc upregulation is essential to sustain the
high rate of cell proliferation of Hpo mutant cells and to protect
PLoS Genetics | www.plosgenetics.org

dmyc is a Hpo pathway target gene regulated by the
activity of Yki
It is well documented that the confrontation of different levels
of dMyc protein between two populations of cells either in vivo
[4,5] or in cell culture [44] can trigger cell competition, however
the molecular mechanism by which this occurs is unknown. In
addition, myc family oncogenes are frequently overexpressed in
human cancers and it contributes to tumor progression of YAPexpressing cells (mammalian orthologue of yki) [17]. We have
previously shown that a transcriptional activation of dmyc occurs
in ft mutant tissues and that ft clones fail to grow in a dmyc
hypomorphic background [45], indicating a possible regulation of
this oncogene by the Hpo pathway. Moreover, the expression
pattern of dMyc is complementary to that of Ds in the wing
imaginal disc (Figure 2A), suggesting a possible functional
interaction. To validate this hypothesis, we analyzed dMyc
2
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Figure 1. yki overexpression confers cells a supercompetitive behavior. (A) yw, hs-Flp, tub-Gal4, UAS-GFP; FRT42D, tub-Gal80/FRT42D, UbiGFP clones induced at 48–72 h AEL. Twin clones are marked by the lack of GFP (0xGFP); imaginal discs were dissected at 120h AEL. (B–E) yw, hsFlp,tub-Gal4, UAS-GFP; FRT42D, tub-Gal80/FRT42D, Ubi-GFP; UAS-yki/+ clones (2xGFP = 2XUbi-GFP+tub-GFP) sorrounded by wild type cells. (B,D)
Clones were induced at 24–48 h AEL and dissected at 120 h AEL (B) or 96h AEL (D). C and E are magnifications of B and D respectively. Cell death
assayed by Caspase 3 staining is shown in red (A–E). Yellow arrowhead indicates a wild type twin in C (0xGFP), whereas the red arrowhead indicates
wild type cells dying far from ykiover clones. Note that wild type cells preferentially die when enclosed by ykiover cells (yellow arrowhead in E). (F–I)
Histograms showing the surface area of wild type and ykiover clones and respective twins induced at 48–72 h AEL and allowed to grow until 120h
AEL. (F, G) Wild type clones (F) and their twins (G) display the same size profile. (H) The size profile of ykiover clones indicates that they are larger either
than wild type controls (F, G) or than their wild type twins (I). Note also that wild type twins (I) of ykiover clones (H) are smaller than wild type clones
induced at the same stage of development (F, G). SEM = Standard Error of the Mean. P,0.0001.
doi:10.1371/journal.pgen.1001140.g001

massively by apoptosis during development [25], we coexpressed
the anti-apoptotic factor p35. As expected, cells coexpressing Hpo
and p35 show reduced levels of dMyc with respect to the control
(Figure S4A) in both late (Figure S4B) and early (Figure S4C)
wing discs. Thus dMyc levels can be regulated by the Hpo
pathway activity.

expression in mutant clones for several members of the Hpo
pathway and in ykiover cells by immunofluorescence. Noticeably,
we found that dMyc was upregulated in a cell-autonomous
manner in ykiover clones throughout the wing disc (Figure 2B and
Figure S3), with the weakest activation in the lateral regions, and
in a subset of clones mutant for several Hpo pathway members
(Figure 2C–2F). These differences in dMyc activation between
ykiover clones and clones mutant for other members of the Hpo
signaling pathway might be due to additional levels of regulation
of the Hpo cascade operating on upstream members. According
to our previous observations, we would predict a repression of
dMyc upon Hpo pathway hyperactivation. To investigate this
hypothesis, we expressed Hpo in the spalt expression domain of
the developing wing disc. Since Hpo overexpressing cells die
PLoS Genetics | www.plosgenetics.org

dmyc is transcriptionally regulated by Yki
dmyc was observed upregulated in RT-PCRs performed on ft
mutant imaginal discs [45], suggesting that it could be a
transcriptional target of the Hpo pathway. In order to investigate
this, we first performed an in situ hybridization in Drosophila wing
discs expressing yki under the control of the decapentaplegic (dpp)
promoter. As expected, dmyc transcript is detectable in the dpp
3
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Figure 2. dmyc oncogene is regulated by the Hpo pathway. (A) Double staining with anti-dMyc (red) and anti-Ds (green) reveals that dMyc
and Ds proteins show a complementary pattern of expression in the wing disc; dMyc is highly expressed in the wing pouch and less in the notum,
while Ds localizes mainly in the hinge and pleura, where dMyc expression is the lowest. (B) dMyc staining of yw, hs-Flp; actFRTy+FRTGal4, UAS-GFP/
UAS-yki Flp-Out clones (GFP+) show increased dMyc protein level. (C–F) dMyc protein levels are increased in dsd36, ftG-rv, exE1 and wtsX1 LOF clones
(arrows). Clones were induced by the Flp/FRT system and are marked by the lack of GFP (0xGFP). Clones were induced at 42–54 h AEL (C–F) or at 54–
66 h AEL (B).
doi:10.1371/journal.pgen.1001140.g002

(not shown). These data indicate a key role for Sd in vivo in
upregulating dMyc in ykiover clones, and in contributing to the
ykiover tumorous phenotype.
Interestingly, examination of dmyc locus revealed the existence
of several CATTCCA repeats in non-coding regions of the gene,
which perfectly match the mammalian [48,49] and Drosophila
[28,29] TEAD/TEF family transcription factor consensus
binding motifs (mammaliam orthologues of Scalloped). In addition, these putative binding motifs for Yki/Sd complexes are
evolutionarily conserved in D. simulans (Figure 3G) and relatively
close to the insertion point of P elements that recapitulate the
endogenous expression of the gene (dmPL35 LacZ [50,51] and
dmBG02383 Gal4 insertions - http://flybase.org/reports/FBti0018138.
html).
To test the significance of these sequences in dmyc regulation, we
generated a dmyc-firefly reporter containing the putative responsive
elements for Yki/Sd complexes (Figure 3H) and performed a
transient dual luciferase assay in S2 cells. As can be seen in
Figure 3I, the reporter was specifically activated upon Sd and Yki
cotransfection but, unexpectedly, the transfection of Yki alone was
able to activate the reporter as efficiently as the cotransfection
Yki/Sd (Figure 3I). This result suggests that in presence of high
levels of Yki alone, additional partners such as Hth [31] could bind
it and co-regulate dmyc expression.
Indeed, complementarily to Yki/Sd complexes, Yki/Hth
complexes seemed to play the same role in the presumptive
thoracic region of the wing disc. Supporting this conclusion, hthRNAi; ykiover clones down-regulated dMyc in the notum (30%
reduction on average, n = 15, P,0,05, Figure S6B, yellow arrows)
and did not grow as tumors in that region. By contrast, they were

domain both in yki and control dmyc-expressing discs (Figure 3A).
No signal within the dpp domain was detected in dpp.GFP control
discs (not shown). We were able to reproduce these data using a
dmyc.lacZ line [46] which recapitulates accurately the dmyc pattern
throughout the wing disc during development [7,47]. As can be
seen in Figure 3B, the ßGal expression is increased in the dpp
domain upon yki expression, indicating that Yki acts upon dmyc
transcription. This result was supported using clonal analysis, both
in ykiover cells, as shown in Figure 3C, and in cells mutant for ft
(Figure S5). Altogether, these data demonstrate the ability of the
Hpo pathway to regulate dmyc transcription in the imaginal wing
disc.
Yki transcriptional activity depends on the formation of tissuespecific complexes with different partners such as Scalloped and
Homothorax [27–31]. In order to study the contribution of Sd to
dmyc upregulation by Yki in the wing disc, we generated ykiover
clones coexpressing either a UAS-sd or a UAS-sd-RNAi construct
(see Figure S6A for validation). As can be seen in Figure 3D, sdover;
ykiover clones overgrew relative to ykiover clones (compare with
Figure 2B, 68% increase on average, n = 27, P,0,005) confirming
previous data [29], but we were not able to detect significant
differences in dMyc protein levels compared to ykiover clones
(n = 22, P = 0,43). As expected, control sdover clones did not
overgrow and did not deregulate dMyc (Figure 3E), demonstrating
that Yki is required for dMyc upregulation. We were not able to
recover sd-RNAi; ykiover clones in the wing pouch region, but
clones generated in other territories of the wing disc, although
large, did not upregulate dMyc (Figure 3F), nor showed the same
degree of hyperplasia as Yki expression alone (Figure 1B–1E). sdRNAi control clones were very small and did not deregulate dMyc
PLoS Genetics | www.plosgenetics.org
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Figure 3. Yki regulates dmyc transcription. (A) In situ hybridization on imaginal wing discs with a full-length dmyc RNA probe. The dmyc
transcript is robustly upregulated in the dpp.yki disc on the left. A dpp.dmyc disc is shown on the right as a control. (B) ßGal staining (red) of
dmyc.lacZG0354/+; dpp.Gal4, UAS-GFP/UAS-yki imaginal wing discs. dmyc expression is upregulated in the dpp domain (GFP+). (C) ßGal staining (red)
of dmyc.lacZG0354/hs-Flp; actFRTy+FRTGal4, UAS-GFP/UAS-yki imaginal wing discs. ykiover clones (GFP+) were induced at 42–54h AEL. As can be
observed, a robust activation of dmyc regulatory sequences is visible within the mutant clones. (D,E) dMyc staining of yw, hs-Flp/+; UAS-sd/+;
actFRTy+FRTGal4, UAS-GFP/UAS-yki and yw, hs-Flp/+; UAS-sd/+; actFRTy+FRTGal4, UAS-GFP/+ imaginal wing discs respectively. Clones (GFP+) were
induced at 42–54 h AEL. As can be observed in E, dMyc levels are comparable inside and outside the mutant clones. (F) dMyc staining of yw, hs-Flp/+;
UAS-sd-RNAi/+; actFRTy+FRTGal4, UAS-GFP/UAS-yki imaginal wing discs. Clones (GFP+) were induced at 42–54 h AEL. No clones in the wing pouch
region were recovered and those outside the wing pouch never took the tumorous shape typical of ykiover clones. All larvae were dissected at 120h
AEL. (G) dIAP1 Hpo Responsive Elements (HRE) for Yki/Sd complexes are indicated in red [28]. The same consensus sites are found twice in the second
intron of dmyc both in D. melanogaster and D. simulans, indicating a possible functional conservation. (H) Scheme of the dmyc locus showing the
exons (E) and introns (I). The red bar indicates the region of the second intron containing the putative Yki/Sd consensus sites. (I) Luciferase assay on
S2 Drosophila cells. NT: cells transfected with dmyc-firefly alone. P value is significative for Sd/Yki (P,0,05) and Yki (P,0,01). Error bars represent
standard deviation (triplicate wells).
doi:10.1371/journal.pgen.1001140.g003

undistinguishable from ykiover clones in the wing pouch region
(Figure S6B, white arrowhead), where Hth expression is almost
undetectable (Figure S6C). Altogether, these latter results indicate
that Sd and Hth play a role in Yki-induced tumorigenesis by
regulating dmyc expression in the wing disc, with Sd playing a more
critical role in the pouch and Hth acting in the presumptive
thorax.

see also Figure S7A, S7A9, and [7] for RNAi construct validation ).
As expected, dmyc-RNAi clones showed a reduced number of cells
with respect to that observed in wild type clones (21% reduction on
average, compare Figure 4B and 4B9 with Figure 4A and 4A9,
P,0.01). The reduction in cell number displayed by the ykiover;
dmyc-RNAi clones with respect to the ykiover clones was even more
evident (43% reduction on average, compare Figure 4D and 4D9
with Figure 4C and 4C9, P,0.01), and this percentage raised up to
65% (n = 87, P,0,001) when these clones were induced earlier in
development (42–54h AEL), indicating a strong cell-autonomous
requirement of dMyc protein for the expansion of ykiover clones. We
also observed that the non-autonomous apoptosis induced by yki
overexpression was reduced upon dmyc deprivation (32% on

dMyc upregulation enhances cell proliferation of the Hpo
pathway mutant cells in an autonomous manner
With the aim to investigate the cell-autonomous contribution of
dMyc overexpression to ykiover phenotypes, we first compared the
size of ykiover clones with that of ykiover; dmyc-RNAi clones (Figure 4,
PLoS Genetics | www.plosgenetics.org
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Figure 4. dMyc boosts the proliferative abilities of ykiover cells. Four types of clones were simultaneously induced through the Flp-Out
system at 48–72h AEL and allowed to grow for a comparable period (until 120h AEL). Clones are GFP+, nuclei are counterstained with DAPI. (A–A9)
act.GFP control clones. (B–B9) act.dmyc-RNAi clones. (C–C9) act.ykiover clones proliferate faster than wild type clones. (D–D9) act.dmyc-RNAi;
ykiover clones: proliferation is reduced relative to act.ykiover clones. (A9–D9) Histograms showing the number of cells/clone of the genotypes
indicated in A–D. SEM = Standard Error of the Mean. P,0.01.
doi:10.1371/journal.pgen.1001140.g004

background to that of ykiover clones generated in a background
ubiquitously overexpressing dmyc under the control of a tubulin (tub)
promoter (cell competition assay, [4,5]). In this assay cells express the
endogenous dmyc gene plus an extra copy of the gene under the
control of a tub promoter that ensures two-to-threefold increase of
dmyc transcript [5]. This extra copy of dmyc is located in a
removable cassette between the tub promoter and a Gal4 cDNA.
Upon dmyc cassette excision, the tub promoter drives Gal4
expression in the clones and, as a result, those cells express lower
levels of dmyc relative to the background and are rapidly eliminated
from the tissue by cell competition. Only few genes have so far
been found whose overexpression rescues cell viability in this
context [5]. The relative difference in dMyc levels between ykiexpressing cells and the surrounding tub.dmyc cells was minimized
in a competitive background compared to a wild type context
(compare Figure S7C and S7C9 with Figure 2B). In this
competitive background, ykiover clones showed a diminished ability
to overgrow compared to a wild type background (44% reduction
on average, compare Figure 6C and 6C9 and Figure 6B and 6B9;
P,0,01). Besides the reduction in size, ykiover clones showed an
important reduction in clone number both in discs (Figure 6C) and
adult wings (compare Figure S7E to Figure S7D). Moreover, ykiover
clones induced earlier in development (42–54h AEL) were never
recovered at the end of larval development (not shown). These
data indicate that the competitive properties of ykiover cells are
extremely reduced when they are surrounded by cells expressing
very high amounts of dMyc.
We then performed the same competition assay as before while
reducing dmyc activity inside the clones. We used the pupal lethal
dmycPL35 allele [49] and, taking advantage of dmyc locus association
to chromosome X, we were able to analyze both female
(heterozygous condition, the expression of dmyc is halved) and
male (hemizygous condition, the expression of dmyc is completely
removed) larvae. In dmycPL35/+; tub.dmyc females, ykiover clones
were smaller than those described in the previous assay (28%
reduction on average, compare Figure 6D and 6D9 to Figure 6C
and 6C9, P,0,05), whereas they were completely outcompeted by
48h after the heat shock in males (not shown). Since it has been
observed that a dmycPL35 heterozygous condition does not impair
cell growth or proliferation rate [49], our results reveal an

average, n = 28, P,0,01, Figure S7B). These data suggest that
dMyc upregulation promotes cell proliferation of ykiover clones in an
autonomous manner, and also promotes their competitive behavior.
To further characterize this proliferation-promoting effect of
dMyc, we compared the clonal behavior of various mutations in
members of the Hpo pathway grown in two different genetic
backgrounds: a wild type context and a genetic background
overexpressing dmyc under the control of a hedgehog promoter in the
posterior (P) compartment of the wing disc. We found that ft, ex
and ds mutant clones were consistently larger in those territories
expressing uniform levels of dMyc than in the wild-type
background (Figure 5 and Figure S8). It is however described
that the overexpression of dMyc is able to autonomously increase
apoptosis [8–11]. In fact, the wild type tissue expressing high
amounts of dMyc tends to die and does not overgrow (see active
Caspase 3 stainings in Figure 5A and 5D). Noticeably, the
apoptosis mediated by dMyc overexpression seems to be extremely
reduced inside ft and ex clones (Figure 5A and 5D) with respect to
the wild type surrounding territories, likely due to the upregulation
of antiapoptotic genes such as dIAP1, a target of the Hpo pthway
[20]. In addition, the dying cells in this genetic background might
induce morphogens to promote compensatory proliferation [52]
that may contribute to the extra-growth of ft- or ex-UAS-dmyc
expressing clones. To circumvent this problem, we repeated the
same experiment coexpressing dmyc and dIAP1. As can be seen in
Figure S9, both ft (Figure S9A) and ex (Figure S9D) mutant clones
grown in the P compartment were still consistently larger than
those originated in the A compartment, thus confirming a specific
cooperation of dmyc and Hpo pathway mutants in clonal
expansion.
Hpo mutant cells therefore seem to show the ability to take
advantage of the cell mass accumulation boosted by dMyc
overexpression to proliferate faster.

dMyc upregulation prevents the Hpo pathway mutant
clones from being restrained in a competitive
background
To address the non-autonomous relevance of dmyc upregulation
in providing ykiover cells with a supercompetitive behavior, we
compared the size of ykiover clones generated in a wild type
PLoS Genetics | www.plosgenetics.org
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cells express low levels of the apoptosis inhibitor dIAP1 (not
shown), this result is not surprising, considering the autonomous
cell death described for cells overexpressing dMyc [11]. However,
yki mutant cells coexpressing dMyc and p35 also failed to grow
(Figure S10C). The lack of expression of additional antiapoptotic
genes and cell cycle regulators [18] possibly impedes the clonal
growth of yki mutant cells even though they overexpress dMyc.
This result suggests that dmyc expression is able to enhance the
ability of Hpo pathway mutant cells to grow, but it is not sufficient
to rescue tissue growth of yki2/2 clones.

Discussion
Cells within a tissue coordinate and execute complex genetic
programs in order to succeed in completing a variety of processes
during development. In this context, the phenomenon of cell
competition may be part of the developmental plan that ensures
removal and replacement of defective cells in growing organs, thus
keeping their size invariant. In this work, we have evaluated in
details the relationships between the phenomenon of cell
competition and the clonal expansion of tumorous cells, using
for that purpose mutants in components of the evolutionarily
conserved Hpo pathway. From our studies we reveal that the Hpo
pathway regulates dMyc expression, and show that this is critical
for the tissue growth and competitive behavior of Hpo pathway
mutant clones.

dMyc is a Hpo pathway transcriptional target
dmyc upregulation has been demonstrated in many studies to
provide cells with supercompetitive properties [4,5,7]. The model
explaining how dMyc can confer competitive properties to cells is
based on the relative levels of this protein in neighboring cell
populations, transforming those cells expressing higher levels of
dMyc into supercompetitors [4,5]. dmyc overexpression is nevertheless insufficient to drive tumorous growth; dmycover clones fail to
overproliferate and show strong autonomous apoptosis [9].
Interestingly, we found that dMyc protein is overexpressed in
Hpo pathway mutant clones, indicating an involvement for this
cascade in dmyc regulation (Figure 2). Furthermore, the upregulation of dMyc in Yki-expressing cells correlates with an increase in
the amount of mRNA, observed by in situ hybridization (Figure 3A)
and using a dmyc.lacZ line (Figure 3B and 3C). Finally, we have
identified a regulatory region in the second intron of dmyc that is
sensitive to Yki abundance; importantly, this regulatory region
includes predicted consensus-binding motifs for Sd (Figure 3H).
Clonal experiments in the wing disc indicate that Sd is necessary
for Yki function in vivo, since upon Sd downregulation Yki is no
longer able to induce tumorous growth and does not upregulate
dMyc (Figure 3F). All these findings support the notion that there
is a transcriptional regulation of dMyc mediated by Yki/Sd
complexes in the wing pouch. Importantly, similar results were
observed for dMyc regulation in the notum by Yki/Hth
complexes, suggesting that tumor growth and dmyc regulation
are tissue-specific.

Figure 5. dMyc overexpression enhances the proliferation of
Hpo pathway mutant cells. ft (A–C) and ex (D–F) LOF clones (0xGFP)
generated in a background where posterior (P) cells ectopically express
dmyc under the control of hh-Gal4 (A and P compartments are
separated by a yellow line in A and D; P is on the right). dMyc
overexpression strongly enhances the proliferative activity of ft (A–C)
and ex (D–F) mutant cells; mutant clones are larger in dMyc-expressing
territories (P compartment in histograms C and F) than in a wild type
background (A compartment in histograms B and E). SEM = Standard
Error of the Mean. P,0.001. High levels of active Caspase 3 signal are
evident in dMyc-expressing cells outside ft and ex mutant clones in the
posterior compartment.
doi:10.1371/journal.pgen.1001140.g005

important role for dmyc-induced cell competition in controlling the
clonal expansion of ykiover cells, which may occur via their nonautonomous capabilities to compete with neighboring wild type
cells.

dMyc expression alone is not sufficient to prevent the
elimination of yki mutant cells
yki LOF clones generated in a wild type background are not able
to grow [16,25] and the ectopic expression of the antiapoptotic
proteins dIAP1 [25] or p35 (Figure S10A) poorly rescues their
viability, whereas a Minute background [53] or bantam overexpression within yki clones has been shown to partially rescue their
growth [25]. Since our results have indicated that dmyc participates
in tumor growth of the Hpo pathway mutant cells, we therefore
analyzed if the expression of dMyc was sufficient to prevent the
death of yki mutant cells. The overexpression of dMyc failed to
rescue the viability of yki2/2 cells (Figure S10B). Since yki mutant
PLoS Genetics | www.plosgenetics.org

What is the contribution of dMyc to the Hpo pathway
mutant phenotypes?
We found that dMyc upregulation is a common feature of Hpo
pathway mutant cells. Since dmyc has been repeatedly associated
with tumor progression and cell competition, we analyzed its role
in the clonal expansion of Hpo pathway mutant cells. We observed
that the reduction of dMyc expression restricts the ability of Hpo
pathway mutant cells to proliferate (Figure 4), whereas its uniform
overexpression strongly promotes their proliferation (Figure 5).
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Figure 6. ykiover clonal expansion is restrained by dmyc-induced cell competition. (A–D9) Cell competition assay shows that, while wild type
clones are outcompeted in this genetic background [5], the clonal expansion of ykiover cells is partially restrained. Clones were induced at 60–84 h
AEL and allowed to grow until 120h AEL. Clones are GFP+, nuclei are counterstained with DAPI. (A–A9) wild type control clones generated through a
tubulin (tub) Flp-OUT system. (B–B9) ykiover clones generated with the same system as the wild type control. (C–C9) ykiover clones in a tub.dmyc
background are smaller than in a wild type background. P,0.01. (D–D9) dmycPL35/+; tub.ykiover clones in a tub.dmyc background are smaller than in
C (P,0.01), confirming that the relative dMyc levels outside vs inside the clones affect the competitive ability of ykiover cells. (A9–D9) Histograms
showing the number of cells/clone of the genotypes indicated in A–D. In C and D discs are larger due to the overall increase in body size of
tub.dmyc individuals [59] SEM = Standard Error of the Mean.
doi:10.1371/journal.pgen.1001140.g006

several types of human cancers [54–56], therefore the mechanism of clonal expansion of Hpo pathway mutant cells in
Drosophila might be relevant to understand tumor progression in
mammals.

Furhermore, while dMyc-expressing wild type cells surrounding
mutant clones are rapidly eliminated by autonomous apoptosis,
Hpo pathway mutant cells are able to take advantage of dMyc role
in protein biosynthesis and cellular growth to divide rapidly. This
is a clear example of functional cooperation between different
genes in order to favor tumor progression, but it also indicates a
specific role of dMyc in promoting the clonal expansion of Hpo
pathway mutant cells. According to these data, we conclude that
dMyc behaves as a growth-promoting factor which sustains the
hyperplastic phenotype of Hpo pathway mutant cells. Importantly,
this specific cooperation might be evolutionarily conserved, since
c-myc appears to be upregulated in a murine model of YAPinduced carcinoma [17].

Materials and Methods
Genotypes and clonal analysis
The fly strains used in the present work were obtained by the
Bloomington Stock Center and are described at http://flybase.bio.
indiana.edu. The following strains were instead obtained by: w;
UAS-yki (D Pan); yw, tubFRTdmycFRTGal4 and yw, dmycPL35,
actFRTy+FRTGal4 (P Gallant); w, hs-FLP; actFRTy+FRTGal4, UASGFP (B Edgar); w; FRT40A, dsD36 (I Rodrı́guez). The UAS-RNAi
constructs for dmyc, sd and hth were obtained from the VDRC.
All experiments were carried out at 25uC unless otherwise
indicated.
MARCM UAS-yki twin-spot clones were induced at different
stages of development by a 35-minutes heat shock at 37uC and
larvae of the following genotype were dissected at either 84-100h
AEL or 120h AEL: yw, hs-Flp, tub-Gal4, UAS-GFP; FRT42D, tubGal80/FRT42D, Ubi-GFP; UAS-yki/+. Clones of the same
genotype were induced 54–66 h AEL and dissected 48h after a
20-minutes heat shock (Figure S1). For FRT-Flp twin analysis, the
following hypomorphic or null alleles were used: dsD36, ftG-rv, exE1,
wtsX1, ykiB5. Loss-of-function clones of ds, ft, ex and wts in either
wild-type or mutant backgrounds overexpressing different transgenes in the posterior compartment were induced at 48–72h AEL
by 1 hour heat shock at 37uC. Larvae of the following genotype
were dissected at 120h AEL:
yw, hs-Flp; FRT40A, Ubi-GFP/FRT40A, dsD36 or ftG-rv or exE1
yw, hs-Flp; FRT82B, Ubi-GFP/FRT82B, wtsX1
yw, hs-Flp; FRT40A, Ubi-GFP/FRT40A, dsD36 or ftG-rv or exE1;
hh-Gal4/UAS-dmyc
yw, hs-Flp; FRT40A, Ubi-GFP/FRT40A, ftG-rv or exE1; hh-Gal4/
UAS-dmyc, UAS-dIAP1

Relative levels of dMyc in neighboring cells restrict/
promote clonal expansion of hyperplastic cells, likely
through cell competition
It has been suggested that cell competition may be a mechanism
potentially restricting the clonal expansion of tumorous cells [7],
but it might also help faster proliferation of transformed cells. Our
data indicate that Hpo pathway mutant cells are able to use high
levels of dMyc to proliferate rapidly (Figure 5), but in a competitive
context, where neighboring cells express high levels of dMyc,
clonal expansion of ykiover cells is restrained (Figure 6), therefore
suggesting a tumor suppressor role for cell competition. Conversely, dMyc upregulation in ykiover clones grown in a wild type
background favors their clonal expansion promoting cell autonomous proliferation and also conferring the ability to outcompete
sourrounding cells in a non-autonomous manner. These findings
suggest that the phenomenon of cell competition may play a dual
role in tumor progression depending on the output of the genetic
interactions occurring between adjacent cells.
In summary, we have shown a tumor-braking gene network in
Drosophila epithelia which tightly controls cell proliferation,
apoptosis and cell competition via the Hpo pathway and dMyc
expression. Importantly, YAP deregulation has been reported in
PLoS Genetics | www.plosgenetics.org
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The size of non-confluent clones was measured drawing each Zstack of the confocal images using ImageJ software (http://rsbweb.
nih.gov/ij). Afterwards the area of the clones was normalized
dividing by the area of the wing pouch, considered as the territory
encircled by the first outer folding of the wing. In Figure S1, the
narrower window of clonal induction allowed us to compare clonal
size without size normalization respect to the wing pouch.
Statistical analysis was performed with Microsoft Excel and R
(www.r-project.org). Statistical significance was determined by two
tailed Student’s t test and reported as the associated probability
value (P).
Flp-Out clones were induced at 60h AEL by a 8-minutes heat
shock at 37uC; imaginal discs of the following genotype were
dissected at 120h AEL:
yw, hs-Flp; actFRTy+FRTGal4, UAS-GFP
yw, hs-Flp; UAS-dmycRNAi/+; actFRTy+FRTGal4, UAS-GFP/+
yw, hs-Flp; actFRTy+FRTGal4, UAS-GFP/UAS-yki
yw, hs-Flp; UAS-dmycRNAi/+; actFRTy+FRTGal4, UAS-GFP/
UAS-yki.
yw, hs-Flp/w, dmyc.lacZG0354; actFRTy+FRTGal4, UAS-GFP/
UAS-yki.
Cell competition assays were performed at 72h AEL inducing a
40-minutes heat shock at 36uC. Larvae of the following genotype
were dissected at 120h AEL:
yw, tubFRTy+FRTGal4/hs-Flp; UAS-GFP/+
yw, tubFRTy+FRTGal4/hs-Flp; UAS-GFP/+; UAS-yki/+
yw, tubFRTdmycFRTGal4/hs-Flp; UAS-GFP/+; UAS-yki/+
yw, dmycPL35, hs-Flp, tubFRTdmycFRTGal4/+-Y; UAS-GFP/+;
UAS-yki/+.
MARCM yki clones overexpressing p35, dMyc or both were
generated at 48–72h AEL by a 45-minutes heat shock at 37uC and
larvae were dissected 48h later.

Luciferase transient expression assays
Drosophila S2 cells were grown at 25uC in Schneider medium
(GIBCO) supplemented with 10% heat-inactivated FCS and 100
units of penicillin.
1189 base pairs located in the second intron of the dmyc
sequence (Figure 3H) were subcloned into a pGL3-firefly vector
(Promega) and co-transfected with Sd and/or Yki-expressing
pAc5.1/V5-HisB plasmids [28] using Effectene Qiagen Transfection Kit. The primers used for that purpose were:
59 CAGCGGTACCAGTTTGCTGTCCTCTGC 39
59GCACTCTAGAGCCATGCGGAATTGTGCG 39.
The PCR product was first cloned in pCR 2.1 TOPO-TA
(Sigma) and then subcloned in KpnI/XhoI sites of pGL3
Promoter vector. For luciferase transient expression assays,
26104 cells were plated in 96-well dishes. Cells were harvested
at 48 hours after transfection and luciferase activity was measured
using the Dual-Luciferase reporter assay system (Promega). DualLuciferase measurements were performed using a FLUOstar
Optima luminometer (BMG Labtech) and normalized to the
Renilla luciferase activity using pAct5C-seapansy as an internal
control. All transient expression data reported in this paper
represent the means from three parallel experiments, each
performed in triplicate. Average relative luciferase activity was
graphed and statistically analyzed by the Student’s t-test.

Supporting Information
Figure S1 ykiover cells supercompetitive behavior is indeed visible

at 48h after induction. (A,B) yw, hs-Flp, tub-Gal4, UAS-GFP;
FRT42D, tub-Gal80/FRT42D, Ubi-GFP (A) and yw, hs-Flp,tubGal4, UAS-GFP; FRT42D, tub-Gal80/FRT42D, Ubi-GFP; UASyki/+ (B) clones induced at 54–66h AEL and dissected 48h after
the heat-shock. Wild type and ykiover clones are GFP2+ and twin
clones are marked by the lack of GFP. Cell death is assayed by
active Caspase 3 inmunoreactivity in red. Note that cell death is
almost absent in the wild type experiment (A0) and marks wild type
cells in the ykiover experiment (B0). (C–F) Histograms showing the
surface area of wild type and ykiover clones and respective twins.
(C,F) Wild type clones (C) and their twins (D) display the same size
profile. (E) The size profile indicates that ykiover clones are larger
than wild type controls (C) as than their wild type twins (F) after
only 48h of growth in the wing. SEM = Standard Error of the
Mean. P,0.0001.
Found at: doi:10.1371/journal.pgen.1001140.s001 (1.60 MB TIF)

Immunofluorescence
Immunostainings were performed using standard protocols.
The following primary antibodies were used: mouse anti-dMyc
(1:5, P Gallant), mouse anti-En (1:50, DSHB), rabbit anti-active
Caspase 3 (1:100, Cell Signaling Technology), rabbit anti-p35
(1:1000, Stratagene), rabbit anti-Ds (1:100, D Strutt), rabbit antiHth (1:400, A Salzberg, [57]), mouse anti-dIAP1 (1:100, B Hay)
and rabbit anti-ßGal (1:400, F Graziani). Anti-mouse and antirabbit Alexa Fluor 555 (1:200) (Molecular Probes) and anti-mouse
Cy5 (1:200) (Jackson Laboratories) against corresponding primary
antibodies were used as secondary antibodies. Imaginal discs were
mounted in Vectashield (Vector Laboratories) for confocal
imaging. Single Z stacks were acquired with Leica SP2 and SP5
confocal microscopes. Images for Figure 4 and Figure 6 were
captured with an epifluorescence Nikon 90i microscope. Entire
images were elaborated with Photoshop CS2 (Adobe) and the
projections along the Z axis were rebuilt starting from 35–55 Z
stacks using the ImageJ public software (NIH). For measurements
of dMyc abundance, fluorescence intensity was calculated using
the ImageJ public software (NIH) as the average gray value within
selectioned portions of confocal Z stacks. For measurement of
active Caspase 3 signal outside UAS-dmyc-RNAi; UAS-yki and
UAS-yki clones, staged wing discs were chosen containing as few
clones as possible and single cells positive to active Caspase 3
observed at a maximum distance of five nuclei (counterstained
with DAPI) from the border of the clone were counted on confocal
Z stacks. In situ hybridization was performed with a full length dmyc
probe [9] on wing imaginal discs of L3 larvae expressing UASGFP, UAS-dmyc or UAS-yki under the control of dpp-Gal4. RNA in
situ hybridization was carried out using digoxigenin-labeled RNA
probes [58].
PLoS Genetics | www.plosgenetics.org

Figure S2 Hpo pathway LOFs induce cell competition. (A,B)

Activated Caspase 3 staining of yw, hs-Flp/+; ftG-rv, FRT40A/
Ubi.GFPnls, FRT40A discs in which mutant clones (0xGFP) were
grown for 48 hours (48–96 in A and 72–120 in B); apoptotic cell
death occurs mainly in wild type cells surrounding the mutant
clones (arrowheads). (C,D) Activated Caspase 3 staining of yw, hsFlp/+; exE1, FRT40A/Ubi.GFPnls, FRT40A (C) and hs-Flp/+;
wtsX1, FRT82B/Ubi.GFPnls, FRT82B (D) discs in which mutant
clones (0xGFP) were grown for a longer period (48–108 and 48–
120 hours respectively); apoptotic death is visible in both wild type
(D, arrowheads) and mutant (D, arrows) cells.
Found at: doi:10.1371/journal.pgen.1001140.s002 (2.75 MB TIF)
dMyc upregulation in ykiover clones is cell-autonomous. dMyc staining in yw, hs-Flp/+; actFTRy+FRTGal4, UASGFP/UAS-yki imaginal wing discs. ykiover clones (GFP+, in green)
express high levels of dMyc (in red) compared to the endogenous
background. Z-section indicates that dMyc (in red) up-regulation is
confined to yki-expressing cells (in green).
Found at: doi:10.1371/journal.pgen.1001140.s003 (0.51 MB TIF)
Figure S3
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Figure S4 Hpo overexpression reduces dMyc protein levels. (A)
dMyc staining in w; sal.Gal4/+; UAS-p35/+ imaginal wing discs.
(B–C) dMyc staining of late (B) and early (C) w; sal.Gal4/+; UASHpo/+; UAS-p35/+ imaginal wing discs. p35 is shown in the green
channel and dMyc in red. As can be observed in the Z-sections
dMyc abundance is lower inside the sal domain. The position of Zsection is indicated by white bars in the surface view of the wing
discs.
Found at: doi:10.1371/journal.pgen.1001140.s004 (2.76 MB TIF)

Figure S8 dMyc overexpression boosts proliferation in ds mutant

cells. (A) ds LOF clones (0xGFP) generated in a background where
posterior cells ectopically express dmyc under the control of the hh
promoter (on the right). dMyc overexpression strongly enhances
the proliferative activity of ds mutant cells; mutant clones are
larger in dMyc-expressing territories (posterior compartment in C)
than in a wild type background (anterior compartment in B).
SEM = Standard Error of the Mean. P,0.001.
Found at: doi:10.1371/journal.pgen.1001140.s008 (0.67 MB
TIF)

Figure S5 dmyc is transcriptionally upregulated in ft mutant
clones. ßGal staining (red) of dmyc.lacZG0354/hs-Flp; ftG-rv,
FRT40/UbiGFPnls, imaginal wing discs. As can be observed, a
robust activation of dmyc regulatory sequences is visible within the
mutant clones (arrows). Larvae were dissected at 120h AEL.
Found at: doi:10.1371/journal.pgen.1001140.s005 (0.93 MB TIF)

Figure S9 dMyc overexpression boosts proliferation of Hpo
pathway mutant cells also when wild type cells are protected from
cell death. ft (A–C) and ex (D–F) LOF clones (0xGFP) generated in
a background where posterior (P) cells ectopically coexpress dmyc
and dIAP1 under the control of hh-Gal4 (A and P compartments
are separated by a white line in A and D; P is on the right). dMyc
overexpression enhances the proliferative activity of ft (A–C) and ex
(D–F) mutant cells; mutant clones are larger in dMyc-dIAP1
expressing territories (P compartment in histograms C and F) than
in a wild type background (A compartment in histograms B and
E). All panels show Caspase 3 staining in red and dIAP1 in blue.
SEM = Standard Error of the Mean. P,0.001.
Found at: doi:10.1371/journal.pgen.1001140.s009 (2.59 MB
TIF)

Figure S6 Hth is necessary for Yki-induced dMyc overexpression in the presumptive thoracic region of the wing disc. (A) Wing
from a w; UAS-sd-RNAi/en.Gal4 individual. For UAS-sd-RNAi
line validation, we induced the expression of the sd-RNAi
construct in the posterior compartment of the wing by means of
the engrailed (en) promoter. As can be observed, the wing lacks the
posterior compartment (green-colored in the insert). (B) dMyc
staining in yw, hs-Flp/+; UAS-hth-RNAi/+; UAS-yki/actFTRy+FRTGal4, UAS-GFP imaginal wing discs. Note that mutant
clones (GFP+) overgrow and overexpress dMyc in the wing pouch
region (white arrowhead) and not in the notum region (yellow
arrows). (C) For UAS-hth-RNAi line validation, we stained for Hth
[57] yw, hs-Flp/+; UAS-hth-RNAi/+; actFTRy+FRTGal4, UASGFP/+ wing discs. Hth expression is lacking in the clone originated
in the pleural region (arrow).
Found at: doi:10.1371/journal.pgen.1001140.s006 (1.49 MB
TIF)

Figure S10 dmyc fails to rescue yki LOF upon inhibition of cell
death. Three types of yki LOF clones were induced through the
MARCM system. In (A), yki mutant clones were generated while
overexpressing the antiapoptotic protein p35 (in red). (B)
Overexpression of dmyc fails to rescue yki mutant cells viability
and Caspase 3 activation (red arrows). (C) The overexpression of
p35 and dmyc together also fails to rescue yki mutant cells viability.
Found at: doi:10.1371/journal.pgen.1001140.s010 (1.47 MB
TIF)

Figure S7 dmyc is involved in the competitive ability of yki. (A)

dMyc levels are strongly affected inside dmyc-RNAi; ykiover clones.
(A9) A projection along the Z axis of the clone presented in Figure
A is shown. The percentage of dMyc abundance reduction inside
the mutant clones calculated as the abatement of fluorescence
intensity (see Methods - Immunofluorescence) with respect to the
neighboring tissue was 62% on average (n = 12). (B) dmyc-RNAi;
ykiover clones display a reduced non-autonomous apoptotic activity
(yellow arrows, see Methods - Immunofluorescence - for
calculation) compared to ykiover clones (see Figure 1). (C) ykiover
clones can compete in a high dmyc level background, where wild
type clones fail to grow; clones were induced at 66–78h AEL and
allowed to grow until 120h AEL. In red, staining for dMyc
indicates that dMyc levels are quite similar inside the ykiover clone
and in the tub.dmyc background. (C9) A projection along the Z
axis of the clone presented in figure C is shown. (D–E) In adult
wings, tub.ykiover clones generated in a wild type background (D)
are bigger than tub.ykiover clones generated in a tub.dmyc
background (red arrows, E) confirming the results illustrated in
Figure 6. Clones were induced at 66–78h AEL and survived up to
the adult stage.
Found at: doi:10.1371/journal.pgen.1001140.s007 (1.18 MB
TIF)
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